The PHQ-9: validity of a brief depression severity measure

Journal of General Internal Medicine
K KroenkeJ B Williams


While considerable attention has focused on improving the detection of depression, assessment of severity is also important in guiding treatment decisions. Therefore, we examined the validity of a brief, new measure of depression severity. The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ-9 was completed by 6,000 patients in 8 primary care clinics and 7 obstetrics-gynecology clinics. Construct validity was assessed using the 20-item Short-Form General Health Survey, self-reported sick days and clinic visits, and symptom-related difficulty. Criterion validity was assessed against an independent structured mental health professional (MHP) interview in a sample of 580 patients. As PHQ-9 depression severity increased, there was a substantial decrease in functional status on all 6 SF-20 subscales. Also, symptom-related difficulty, sick days, and health care utilization increased. Using the MHP reinterview as the criterion standard, a PHQ-9 score > or =10 had a sensitivity of 88% and a specificity of 88% for major de...Continue Reading

Associated Clinical Trials

Jul 6, 2016·Kerry E. Evers
Mar 1, 2017·Derek Richards


Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Feb 11, 1991·Medical Care·D M BerwickM C Weinstein
Mar 1, 1989·Medical Care·L E KazisR F Meenan
May 1, 1986·Acta Psychiatrica Scandinavica·J DavidsonK Graves
Jun 15, 1995·Annals of Internal Medicine·C D MulrowC Kerber
Oct 1, 1996·Archives of General Psychiatry·W KatonE Walker
Jul 1, 1997·Journal of General Internal Medicine·M A WhooleyW S Browner
Dec 1, 1998·JAMA : the Journal of the American Medical Association·M B KellerW Harrison
May 13, 1999·The American Journal of Medicine·J W WilliamsS Lee
Sep 23, 2000·JAMA : the Journal of the American Medical Association·J W WilliamsA Sengupta

❮ Previous
Next ❯


Jul 10, 2004·Journal of General Internal Medicine·Teri GrecoKurt Kroenke
Jan 12, 2005·The Diabetes Educator·Lonnie K WenMichael L Parchman
Dec 22, 2004·Journal of General Internal Medicine·Russell E GlasgowHilarea Amthauer
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathleen EllChristy Russell
Mar 24, 2005·Psychosomatic Medicine·Michael Von KorffTerry Bush
Jan 29, 2005·Stroke; a Journal of Cerebral Circulation·Linda S WilliamsKurt Kroenke
Oct 11, 2005·Administration and Policy in Mental Health·Bruce L RollmanHerbert C Schulberg
Jun 21, 2005·Journal of General Internal Medicine·Raz GrossMyrna M Weissman
Jul 30, 2005·Journal of General Internal Medicine·Alejandra Pinto-MezaJosep Maria Haro
Jun 25, 2005·Mental Health Services Research·Kathryn RostRichard C Hermann
Jul 28, 2005·Alcoholism, Clinical and Experimental Research·R Scott BraithwaiteAmy C Justice
Aug 4, 2005·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Usman HameedFrancesca Bertone
Jan 21, 2006·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·Tamilyn BakasLinda S Williams
Jan 21, 2006·Journal of General Internal Medicine·David W OslinIra R Katz
Nov 15, 2005·AIDS·Sanjay BasuR Douglas Bruce
Dec 13, 2005·Nephron. Clinical Practice·Michelle C OddenMichael G Shlipak
Jul 1, 2006·Journal of General Internal Medicine·Frederick Y HuangRobert L Spitzer
Aug 16, 2006·BMC Family Practice·Nancy S MorrisBenjamin Littenberg
Sep 19, 2006·Nursing Research·Tamilyn BakasLinda S Williams
Aug 2, 2006·Journal of General Internal Medicine·Margaret ShihTeresa J Brady
Sep 7, 2006·International Journal of Geriatric Psychiatry·Albert YeungMaurizio Fava
Dec 13, 2006·Harvard Review of Psychiatry·Jeff C HuffmanGregory L Fricchione
Apr 26, 2007·Clinical Trials : Journal of the Society for Clinical Trials·Miles McFallPhilip W Lavori
Mar 3, 2007·Clinical Rheumatology·Thomas RosemannJoachim Szecsenyi
Feb 10, 2007·Psychosomatic Medicine·Lisa C BarryHarlan M Krumholz
Aug 1, 2007·Arthritis and Rheumatism·Brett D ThombsMurray Baron
May 24, 2007·AIDS Patient Care and STDs·Faika ZanjaniDavid Oslin
May 23, 2007·The Clinical Journal of Pain·Marieke M WollaarsNico Brand
Aug 10, 2007·Current Pain and Headache Reports·Karen O Anderson
Sep 7, 2007·Psychological Medicine·D A RichardsR Richardson
Oct 16, 2007·Digestive Diseases and Sciences·Nader DboukAasim Sheikh
Jan 9, 2008·Evaluation & the Health Professions·Roger A BoothroydHuey Jen Chen
Dec 6, 2007·Expert Review of Neurotherapeutics·Jeanne Leventhal AlexanderEnid M Hunkeler
May 6, 2008·Maternal and Child Health Journal·Patricia A Harrison, Abbey C Sidebottom
Dec 29, 2007·The American Journal of Drug and Alcohol Abuse·Jennifer S PotterRoger D Weiss
Sep 18, 2007·Journal of General Internal Medicine·Simon GilbodyCatherine Hewitt

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.